Stockscreener 앱 받기
5.88
0.34%
0.03
전일 마감가:
$5.91
열려 있는:
$5.95
하루 거래량:
8,051
Relative Volume:
0.06
시가총액:
$294.78M
수익:
$13.56M
순이익/손실:
$-26.97M
주가수익비율:
-10.24
EPS:
-0.5742
순현금흐름:
$-24.04M
1주 성능:
-8.20%
1개월 성능:
-15.53%
6개월 성능:
+26.71%
1년 성능:
+48.99%
1일 변동 폭
$5.89
$5.95
1주일 범위
$5.895
$6.755
52주 변동 폭
$3.4341
$15.37
Capsovision Inc Stock (CV) Company Profile
명칭
Capsovision Inc
전화
(408) 370-4790
주소
18805 COX AVENUE SUITE 250, SARATOGA
Compare CV vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CV
Capsovision Inc
|
5.89 | 306.29M | 13.56M | -26.97M | -24.04M | -0.5742 |
ABT
Abbott Laboratories
|
114.48 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
330.81 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.26 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.71 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.75 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Capsovision Inc Stock (CV) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-28 | 개시 | Roth Capital | Buy |
| 2025-07-28 | 개시 | The Benchmark Company | Speculative Buy |
Capsovision Inc 주식(CV)의 최신 뉴스
CapsoVision (CV) Earnings Update: The Bottom-Line Figure Trails Its Comparison; Latest Reaction: The Stock Ends Down 0.49%Basic EPS Analysis - Vinanet
CapsoVision Initiates $100 Million At-the-Market Equity Offering with Cantor Fitzgerald - Kalkine Media
CapsoVision Launches $100 Million At-The-Market Offering - TipRanks
CapsoVision launches $100M at-the-market equity program with Cantor Fitzgerald - TradingView
The CapsoVision, Inc. (NASDAQ:CV) Second-Quarter Results Are Out And Analysts Have Published New Forecasts - 富途牛牛
CapsoVision Earnings Call: Growth, AI Push, Margin Strain - TipRanks
CapsoVision stock rating maintained at Speculative Buy by Benchmark - Investing.com
CapsoVision (CV) Q2 2026 Earnings Call: Umsatz steigt um 10 %, KI-Einführung schreitet voran - TradingKey
CapsoVision Inc (CV) (Q2 2026) Earnings Call Highlights: AI Launch Drives Growth Amid Pricing ... By GuruFocus - Investing.com Canada
CapsoVision (CV) Stock Rich Valuation Meets Widening Losses - Sahm
CapsoVision Q2 Earnings Call Highlights - MarketBeat
CAPSOVISION ($CV) Releases Q2 2026 Earnings - Quiver Quantitative
CapsoVision Reports Q2 2026 Financials: Inventory Growth and Balance Sheet Update - Kalkine Media
CapsoVision Q2 Results: Revenue rises 10% to $3.6 million - scanx.trade
Earnings call transcript: CapsoVision Q2 2026 loss widens as shares fall after hours - Investing.com
CapsoVision Files Mixed Shelf for Up to $250 Million in Securities - marketscreener.com
CapsoVision Q2 2026 Earnings Call Transcript - Benzinga
CapsoVision Launches $100 Million At-the-Market Equity Program - TipRanks
CapsovisionMay Offer Up To $250 Million Of Common Stock, Preferred Stock, Warrants, Rights, And Units - TradingView
CapsoVision (CV) widens losses in H1 2026 and flags going concern risk - Stock Titan
CapsoVision, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
CapsoVision, Inc. Provides Revenue Guidance for the Second Half of 2026 - marketscreener.com
CapsoVision Reports Second Quarter 2026 Financial Results - Yahoo Finance
CapsoVision Inc (CV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
CapsoVision Inc (CV) Stock News Today - TradingKey
CV Q1 2026 Earnings: Loss Per Share Widens to -$0.15, Shares Still Gain 1.92EPS Revision Trend - Vinanet
CapsoVision launches AI feature for capsule endoscopy abroad By Investing.com - Investing.com Canada
CapsoVision® Announces International Launch of AI Highlights - The Manila Times
CapsoVision launches AI feature for capsule endoscopy abroad - Investing.com
CapsoVision (CV) Jumps Nearly 9% to $7.17, Approaching Key Resistance at $7.53Day Trade Opportunities - dars.gov.et
CV|CapsoVision Inc|Price:6.580|Chg%:-0.120 - tradingkey.com
CapsoVision to Release Second Quarter 2026 Financial Results on August 13, 2026 - GlobeNewswire
CapsoVision Inc. (CV) Q1 2026 Earnings: Wider-Than-Expected Loss Amid Limited DisclosureRevenue Guidance Update - dars.gov.et
CapsoVision (NASDAQ:CV) Major Shareholder Purchases 61,068 Shares of Stock - MarketBeat
CapsoVision Inc (CV) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
CV|CapsoVision Inc|Price:6.620|Chg%:+0.130 - TradingKey
CapsoVision Inc (CV) Cash Flow - TradingKey
CapsoVision Inc (CV) Balance Sheet - TradingKey
CapsoVision Inc (CV) Income Statement - TradingKey
CapsoVision Inc (CV) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
CapsoVision Inc (CV) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CapsoVision Inc (CV) Valuation: PE, PB & Fair Value Analysis - TradingKey
CV|CapsoVision Inc|Price:6.540|Chg%:+0.050 - TradingKey
CapsoVision Inc (CV) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Form 4 CapsoVision Inc For: 21 July By Investing.com - Investing.com Canada
CapsoVision director Eliyahou Harari buys $410k in company stock - Investing.com
CapsoVision director Eliyahou Harari buys $410k in company stock By Investing.com - Investing.com Nigeria
CapsoVision 10% owner Eliyahou Harari reports purchase of 61,068 common shares for $410,987.64 - Bitget
CapsoVision (CV) Q1 2026 Earnings: EPS Misses Estimates Amid Absent Revenue DisclosureEPS Guidance Update - Vinanet
CapsoVision Inc. (CV) Surges Over 5% – Testing Key Resistance LevelsTurnaround Stocks - dars.gov.et
U.S. Smart Pills Market to Reach US$ 619.10 Million by 2033 as - openPR.com
Capsovision Inc (CV) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.52%
1.02%
자본화:
|
볼륨(24시간):